Effect of donor/recipient sex on clinical extensive chronic GVHD
Donor/recipient sex . | Adjusted odds ratio* . | 95% CI . | P . |
|---|---|---|---|
| Female/male | 1 | NA | NA |
| Male/female | 0.68 | 0.56-0.82 | < .0001 |
| Female/female | 0.63 | 0.51-0.76 | < .0001 |
| Male/male | 0.64 | 0.54-0.76 | < .0001 |
Donor/recipient sex . | Adjusted odds ratio* . | 95% CI . | P . |
|---|---|---|---|
| Female/male | 1 | NA | NA |
| Male/female | 0.68 | 0.56-0.82 | < .0001 |
| Female/female | 0.63 | 0.51-0.76 | < .0001 |
| Male/male | 0.64 | 0.54-0.76 | < .0001 |
NA indicates not applicable.
Adjusted for patient and donor age, GVHD prophylaxis, disease status, conditioning regimen, and patient/donor CMV serostatus.